Asia-Pacific insurers have sufficient capital buffers to absorb investment and underwriting stresses from the Middle East conflict, in S&P Global Ratings' (S&P) base case.
However, geopolitical uncertainty and trade policy swings could amplify financial market volatility, eroding insurers' capital buffers.
S&P Analyst Mr Philip Chung made these comments in a new report, titled “Credit Conditions Asia-Pacific Q2 2026: Choke Point To Stress Points”, on the impact of the Middle East conflict on various sectors and markets in the region.
He outlined the key risks around the baseline as follows:
Supply-chain disruptions and geopolitical tensions. Supply-chain disruptions and escalation in geopolitical tensions could fuel inflation, dampen economic growth and elevate financial market volatility. Interest rate differentials and unhedged foreign exchange positions could increase balance sheet volatility.
Slower economic growth and weaker household budgets. An economic slowdown could stifle insurance demand from households and businesses, and it may squeeze insurers' margins.
Evolving risks to monitor. Climate change could render some areas uninsurable. While Asia Pacific insurers have limited investments in private credit, stresses in the private-credit ecosystem outside Asia Pacific could spill over to the region and weaken credit and financing conditions. S&P assumes concerted industry effort and repricing will address medical cost inflation.
Implications for the insurance sector
A test of risk management capabilities and capital resilience. Financial market volatility and unhedged foreign exchange positions will pressure earnings and test balance sheet resilience--particularly for insurers with unhedged overseas investments. Japanese insurers will likely harness unrealised gains from the sale of domestic equities and use price fluctuation reserves to buffer reported profits from realized losses on domestic bond sales.
Increasing margin pressure. The drive to enhance investment yield could raise the attractiveness of alternative or private investments, thus exposing insurers to potential credit stress. Medical inflation could render insurance unaffordable. Supply-chain disruptions may drive higher inflation and increase insurer expenses and claims costs. Underwriting margins may erode if pricing fails to keep up with deteriorating claim experience.